Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Incyte Corporation    INCY   US45337C1027

INCYTE CORPORATION

 (INCY)
4
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Latest news on INCYTE CORPORATION
2011 INCYTE: Submits New Drug Applicationfor Ruxolitinib in Myelofibrosis to the US ..
2011 INCYTE: Submits New Drug Application for Ruxolitinib in Myelofibrosis to the US..
2011 INCYTE: Announces Ruxolitinib (INC424) Shows Significant Clinical Benefit for M..
2011 INCYTE: to Present at Upcoming Investor Conferences
2011 INCYTE: Reports First Quarter 2011 Financial Results and Program Updates
2011 INCYTE: to Present at the Bank of America Merrill Lynch Healthcare Conference
2011 INCYTE: to Report First Quarter 2011 Financial Results and Provide Update on Dr..
2011 INCYTE: Achieves $15 Million Milestone for c-MET Inhibitor Oncology Program
2011 INCYTE: Incyte's Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase..
2011 INCYTE: to Present at the Cowen and Company 31st Annual Health Care Conference
2011 INCYTE: Reports 2010 Financial Results; Provides 2011 Key Objectives and Financ..
2011 INCYTE: to Report 2010 Financial Results and Provide 2011 Key Objectives and Fi..
2011 INCYTE: to Present at the 29th Annual J.P. Morgan Healthcare Conference
2010 INCYTE: Announces Positive Top-Line Results from COMFORT-I Pivotal Phase III Tr..
2010 INCYTE: Presents Positive Long-Term Results from Ongoing Phase II Trial of INCB..
2010 INCYTE: to Present at the 22nd Annual Piper Jaffray Health Care Conference
2010 INCYTE: Incyte's Selective Oral JAK1 and JAK2 Inhibitor Demonstrates Positive P..
2010 INCYTE: to Host Webcast at 2010 ACR/ARHP Annual Scientific Meeting
2010 INCYTE: Reports Third Quarter 2010 Financial Results and Provides Update on Dru..
2010 INCYTE: Achieves $50 Million in Milestones for Initiation of a Joint Global Pha..
2010 INCYTE: to Report Third Quarter 2010 Financial Results and Provide Update on Dr..
2010 INCYTE: to Present at the Oppenheimer 21st Annual Healthcare Conference
2010 INCYTE: Achieves $19 Million Milestone as Novel JAK1 and JAK2 Inhibitor Advance..
2010 INCYTE: Phase I/II Data Published in New England Journal of Medicine Demonstrat..
2010 INCYTE: Reaches Agreement with the FDA on a Special Protocol Assessment for the..
2010 INCYTE: to Present at Upcoming Investor Conferences
2010 INCYTE: Reports Second Quarter 2010 Financial Results
2010 INCYTE: to Report Second Quarter 2010 Financial Results and Provide Update on D..
2010 INCYTE: Results from an Ongoing Phase I/II Trial of Oral INCB7839 Presented at ..
2010 INCYTE: to Present at Upcoming Investor Conferences
2010 INCYTE: Appoints Wendy Dixon, Ph.D., to Its Board of Directors
2010 INCYTE: to Present at the Citi Investment Research 2010 Global Health Care Conf..
2009 INCYTE: Lilly and Incyte Announce Collaboration for Development and Commerciali..
2008 INCYTE: Beacon Equity Issues Technical Trade Alerts on Biotechnology Stocks: AM..
2007 INCYTE CORP: Data Presented at the 47th Annual Interscience Conference on Antim..
2007 INCYTE CORP: Incyte to Present at the 2007 UBS Global Life Sciences Conference
2007 INCYTE CORP: Incyte Cites Encouraging Clinical Data in Multiple Programs; Annou..
2007 INCYTE CORP: Phase IIa Study Results Demonstrate that Once-Daily 200 mg Dosing ..
2007 INCYTE CORP: Incyte to Report Second Quarter 2007 Financial Results and Provide..
2007 INCYTE CORP: Incyte to Present at Upcoming Investor Conferences
2007 INCYTE CORP: Incyte to Present at Upcoming Investment Conferences
2007 INCYTE CORP: Incyte Reviews Progress in Multiple Drug Development Programs and ..
2007 INCYTE CORP: Incyte to Present at the Morgan Stanley Global Healthcare Unplugge..
2007 INCYTE CORP: Incyte to Report First Quarter 2007 Financial Results and Provide ..
2007 INCYTE CORP: Incyte Reviews Recent Progress in Multiple Programs; Announces 200..
2007 INCYTE CORP: Incyte to Report 2006 Financial Results and 2007 Financial Guidanc..
2007 INCYTE CORP: Incyte to Report Positive Preliminary Clinical Results from HIV an..
2007 INCYTE CORP: Incyte to Present at the 25th Annual JP Morgan Healthcare Conferen..
2006 INCYTE CORP: Registration Statement Declared Effective for the Resale of Incyte..
2006 INCYTE CORP: Incyte to Present at 18th Annual Piper Jaffray Health Care Confere..
2006 INCYTE CORP: Incyte Announces Filing of Registration Statement for Resale of 3 ..
2006 INCYTE CORP: Incyte to Present at JMP Securities Healthcare Conference
2006 INCYTE CORP: Incyte Reports Continued Progress in Multiple Drug Discovery and D..
2006 INCYTE CORP: Incyte to Report Third Quarter 2006 Financial Results and Provide ..
2006 INCYTE CORP: Incyte Completes Note Offering and Announces Redemption of Outstan..
2006 INCYTE CORP: Incyte to Present at UBS Global Life Sciences Conference
2006 INCYTE CORP: Incyte Announces Offering of Convertible Senior Notes; Net Proceed..
2006 INCYTE CORP: Incyte to Present at Thomas Weisel Partners Healthcare Conference
2006 INCYTE CORP: Incyte Announces Second Quarter Financial Results; Provides Update..
2006 INCYTE CORP: Incyte to Report Second Quarter 2006 Financial Results; Provide Up..
2006 INCYTE CORP: Incyte Invites Investors to Listen to Webcast of Presentation at t..
Prev.1   2
Advertisement
Chart
Duration : Period :
Incyte Corporation Technical Analysis Chart | INCY | US45337C1027 | 4-Traders
Income Statement Evolution
Incyte Corporation : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.